We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Can Sanmina's Diversified Medical Portfolio Boost Its Competitive Edge?
Read MoreHide Full Article
Key Takeaways
SANM manufactures diverse medical devices, from diagnostic equipment to surgical robots.
Its end-to-end services cover design, engineering, assembly, testing, repair and supply chain management.
Sanmina partners with Microbot Medical to manufacture its LIBERTY robotic system.
Sanmina Corporation (SANM - Free Report) is a global manufacturing company serving the healthcare and medical technology industry. It works with medical device manufacturers to design, develop and produce advanced medical equipment. The company continues to strengthen its healthcare business through investments in diagnostic systems and advanced manufacturing technologies.
Sanmina manufactures and supports a wide range of medical technologies, including CT scanners, MRI machines, X-ray and ultrasound equipment, and diagnostic systems. Its medical portfolio also covers blood glucose meters, thermometers, wearable health monitors, disposable insulin pumps, continuous glucose monitors, patient monitoring systems, pulse oximeters and surgical robotic systems. The company supports cardiovascular and respiratory care technologies, including pacemakers, cardiac monitors and ventilators.
The company provides complete manufacturing services for medical products, including design, engineering, electronic assembly, testing and repair. It manages supply chain operations to ensure smooth sourcing, production and product delivery. Sanmina also manufactures single-use and personal healthcare devices through automated production processes. Its medical facilities follow quality and safety standards, including ISO 13485, FDA requirements and MDSAP certification at selected locations.
Sanmina has partnered with Microbot Medical to manufacture its LIBERTY Endovascular Robotic System, strengthening its presence in the medical robotics market. With its global manufacturing network and engineering expertise, the company is well positioned to benefit from the growing demand for advanced medical devices and healthcare technologies.
How Are Competitors Advancing in the Healthcare Sector?
Sanmina faces competition from Jabil, Inc. (JBL - Free Report) and Celestica Inc. (CLS - Free Report) . Jabil is expanding its presence in the healthcare sector by providing manufacturing and supply chain solutions for medical device and pharmaceutical companies. Its capabilities cover drug delivery systems, diagnostic equipment, patient monitoring devices and connected healthcare technologies. Jabil supports product development, specialized packaging and large-scale production to help healthcare customers bring innovative products to market.
Celestica is strengthening its healthcare business through advanced electronics manufacturing and system integration capabilities. It supports medical applications such as diagnostic imaging, surgical robotics, laboratory testing equipment and minimally invasive medical devices. Celestica focuses on precision engineering, complex electronic assemblies and high-reliability manufacturing to meet the growing demand for advanced medical technologies.
SANM's Price Performance, Valuation & Estimates
Sanmina shares have plunged 22.8% compared with the industry’s decline of 18%.
Image Source: Zacks Investment Research
From a valuation standpoint, the company’s shares currently trade at 9.33 forward 12-month earnings, lower than the industry tally of 12.33.
Image Source: Zacks Investment Research
Earnings estimates for 2026 have moved up 0.1% to $12.12 per share over the past 60 days, while the same for 2027 has increased 1.4% to $14.14.
View the Zacks #1 Rank List
Image: Bigstock
Can Sanmina's Diversified Medical Portfolio Boost Its Competitive Edge?
Key Takeaways
Sanmina Corporation (SANM - Free Report) is a global manufacturing company serving the healthcare and medical technology industry. It works with medical device manufacturers to design, develop and produce advanced medical equipment. The company continues to strengthen its healthcare business through investments in diagnostic systems and advanced manufacturing technologies.
Sanmina manufactures and supports a wide range of medical technologies, including CT scanners, MRI machines, X-ray and ultrasound equipment, and diagnostic systems. Its medical portfolio also covers blood glucose meters, thermometers, wearable health monitors, disposable insulin pumps, continuous glucose monitors, patient monitoring systems, pulse oximeters and surgical robotic systems. The company supports cardiovascular and respiratory care technologies, including pacemakers, cardiac monitors and ventilators.
The company provides complete manufacturing services for medical products, including design, engineering, electronic assembly, testing and repair. It manages supply chain operations to ensure smooth sourcing, production and product delivery. Sanmina also manufactures single-use and personal healthcare devices through automated production processes. Its medical facilities follow quality and safety standards, including ISO 13485, FDA requirements and MDSAP certification at selected locations.
Sanmina has partnered with Microbot Medical to manufacture its LIBERTY Endovascular Robotic System, strengthening its presence in the medical robotics market. With its global manufacturing network and engineering expertise, the company is well positioned to benefit from the growing demand for advanced medical devices and healthcare technologies.
How Are Competitors Advancing in the Healthcare Sector?
Sanmina faces competition from Jabil, Inc. (JBL - Free Report) and Celestica Inc. (CLS - Free Report) . Jabil is expanding its presence in the healthcare sector by providing manufacturing and supply chain solutions for medical device and pharmaceutical companies. Its capabilities cover drug delivery systems, diagnostic equipment, patient monitoring devices and connected healthcare technologies. Jabil supports product development, specialized packaging and large-scale production to help healthcare customers bring innovative products to market.
Celestica is strengthening its healthcare business through advanced electronics manufacturing and system integration capabilities. It supports medical applications such as diagnostic imaging, surgical robotics, laboratory testing equipment and minimally invasive medical devices. Celestica focuses on precision engineering, complex electronic assemblies and high-reliability manufacturing to meet the growing demand for advanced medical technologies.
SANM's Price Performance, Valuation & Estimates
Sanmina shares have plunged 22.8% compared with the industry’s decline of 18%.
Image Source: Zacks Investment Research
From a valuation standpoint, the company’s shares currently trade at 9.33 forward 12-month earnings, lower than the industry tally of 12.33.
Image Source: Zacks Investment Research
Earnings estimates for 2026 have moved up 0.1% to $12.12 per share over the past 60 days, while the same for 2027 has increased 1.4% to $14.14.
Image Source: Zacks Investment Research
Sanmina currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.